Boston Family Office’s Elevance Health ELV Stock Holding History

Boston Family Office’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,349	Closed	-$221K	–	240
2015 Q2	$221K	Hold	1,349	–	–	0.03%	245
2015 Q1	$208K	Buy	+1,349	New	+$192K	0.03%	252

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Family Office's ELV Position: Q3 2015 in Review

Boston Family Office sold out of Elevance Health (ELV) in Q3 2015, closing a stake of 1,349 shares — an estimated $221K sold.

Boston Family Office first reported a position in ELV in Q1 2015 and held it in 2 quarters. The position peaked at $221K in Q2 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q3 2015.

Boston Family Office reported no remaining Elevance Health position as of Q3 2015 after selling out during the quarter.
Boston Family Office sold 1,349 Elevance Health shares in Q3 2015, an estimated $221K.
Boston Family Office first reported a position in Elevance Health in Q1 2015 and held it in 2 quarters.
Boston Family Office's Elevance Health position peaked at $221K in Q2 2015.
760 funds tracked by Wall St. Rank held Elevance Health as of Q3 2015.

Based on Boston Family Office's 13F filing for Q3 2015, filed 4 Nov 2015.